Member Info for TheOriginalNova

There is no coded message.
The FCA gave firms a 2 month extension to submit their yearly results. Why wouldn't you use that time if you're busy?

Called it -

Notification of 2019 final results

Due to a longer review process of the financial statements caused by COVID-19, the Company now intends to report its audited results for the year ended 31 December 2019 during the week commencing 11 May 2020.

https://www.boots.jobs/jobs/124058br-covid-19-tester-2/?c=1

It's the French 700k/week testing driving this. That's what they're all talking about on the French board.
Heavy expectation that there will be an RNS announcing French orders over there.

The FCA announced have given firms a 2 month extension to publish their annual results because of the current climate.
As Novacyt and (understandably) busy, do we really expect them to publish theirs right now? I'm sure they have bigger things to worry about.

Hi all

I see that it's a holiday in France on Friday. Does anyone know if their markets will be open?
If not, how will that effect our movements?

The question is, what is a realistic P/E? - That's a serious question if anyone has any suggestions?
An average P/E for a pharma is around 23 or so, isn't it? But a P/E that high can only be justified if the earnings are going to run long term.
Let's be real, no matter what your position is, this current climate will end at some point and testing will no longer be relevant. I'm hoping for a P/E of 7 (based on previous sales data / guessing and SP at the time). But that number is on the verge of being plucked out of the sky.

I agree, Lloyd.
I believe there is a big market for both, but at this point in time there is too much emphasis on antibody tests. But if an antibody test can be proven then there is definitely a place for it, after mass testing using antigen.

We can live in hope. That would surely be a game changer!

I thought... We know that a direct to PCR test is due next month. Could there be a curve ball thrown and actually be an antibody version?
That might be a stretch to suggest, but it wouldn't be a big surprise to find out they've been developing an anitbody test.

That's very curious. I'm sure this must be a mistake?
If they had received CE approval for an antibody test, I'm sure an RNS would have been released.

Interesting that the ship date is 4th May, a week away.

https://www.attogene.com/shop/coronavirus-covid-19-strain-ce-ivd/
$1550 = $16.15/test

"The genesig qPCR detection kits for nCoV-2019 allows specific early detection of the virus."
Novacyt kit. I think we can put the 2 together...

The stats line up with the Primerdesign test. Could they be re branded versions?

Apologies, may has misread.

https://www.meslo.com/category/704/Coronavirus-qPCR-test-Kits-COVID-19.html

Offices in Cyprus and Dubai.

What's changed, Spurs?

Another thought to add to the list -
The FDA approved the Qiagen kit for use of PrimerDesign tests. Another TF relation?

https://www.boursorama.com/cours/1rPALNOV/
Or stick epa:alnov in Google.

France are up 14% because we closed higher than they did yesterday. Convert the France price to £ and you'll see they are similar.

dereamping*